Founded in 2005, Catalysis Capital Partners is an independent Investment Banks & Service Providers boutique primarily focused on the life sciences industry. Based in London, United Kingdom, the firm advises on sell-side, spin-off, and buy-side assignments and has experience in the separation of assets as well as the bundling of associated intellectual property. Catalysis also advises on the placement of preferred securities, structuring convertible note transactions as well as secondary share placements.